Abstract
Purpose
The α2-adrenergic receptor agonist dexmedetomidine reportedly weakens heart rate (HR) responses to ‘rapid’ (during a few seconds) reduction in arterial pressure, but does not affect HR responses to ‘gradual’ (during 60 s) reduction in arterial pressure. As the speed of neurotransmission along the parasympathetic nerve is relatively rapid, alteration of parasympathetic-mediated arterial-cardiac baroreflex function plays a more important role in HR responses to ‘rapid’ changes in arterial pressure. We therefore hypothesized that dexmedetomidine attenuates parasympathetic-mediated arterial-cardiac baroreflex function.
Methods
Twelve healthy men received placebo, low-dose (loading, 3 μg/kg/h for 10 min; maintenance, 0.2 μg/kg/h for 60 min) (low-DEX), or moderate-dose (loading, 6 μg/kg/h for 10 min; maintenance, 0.4 μg/kg/h for 60 min) (moderate-DEX) dexmedetomidine infusions in a randomized, double-blind, crossover study. Before and after 70 min of infusion, arterial-cardiac baroreflex function was assessed by spectral and transfer function analysis between arterial pressure variability and HR variability.
Results
The high-frequency power of systolic arterial pressure (SAP) variability increased significantly with low-DEX and moderate-DEX infusions (significant interaction effects, P = 0.005), whereas the high-frequency power of R-wave–R-wave interval (RRI) variability (as an index of cardiac parasympathetic activity) did not change significantly at any dose infusions. Then, transfer function gain in the high-frequency range (as an index of parasympathetic arterial-cardiac baroreflex) decreased significantly with low-DEX and moderate-DEX infusions (significant interaction effects, P = 0.007).
Conclusions
The present results suggest that dexmedetomidine attenuates parasympathetic-mediated arterial-cardiac baroreflex function, implying weakened HR response to ‘rapid’ reduction in arterial pressure.
Similar content being viewed by others
References
Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003;29:201–7.
Kunisawa T, Nagashima M, Hanada S, Suzuki A, Takahata O, Iwasaki H. Awake intubation under sedation using target-controlled infusion of dexmedetomidine: five case reports. J Anesth. 2010;24:789–92.
Turan A, Sen H, Sizlan A, Yanarateş O, Ozkan S, Koyuncu O, Dağli G. Dexmedetomidine: an alternation for epidural anesthesia in tension-free vaginal-tape surgery. J Anesth. 2011;25:386–91.
Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–94.
Drew GM, Whiting SB. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Anaesth. 1979;67:207–15.
Hogue CW Jr, Talke P, Stein PK, Richardson C, Domitrovich PP, Sessler DI. Autonomic nervous system responses during sedative infusions of dexmedetomidine. Anesthesiology. 2002;97:592–8.
Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1981;32:337–61.
Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribution of α2 agonist binding sites in the rat and human central nervous system: analysis of some functional, autonomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev. 1984;7:69–101.
Kato J, Ogawa Y, Kojima W, Aoki K, Ogawa S, Iwasaki K. Cardiovascular reflex responses to temporal reduction in arterial pressure during dexmedetomidine infusion: a double-blind, randomized and placebo-controlled study. Br J Anaesth. 2009;103:561–5.
Persson PB, Di Rienzo M, Castiglioni P, Cerutti C, Pagani M, Honzikova N, Akselrod S, Parati G. Time versus frequency domain techniques for assessing baroreflex sensitivity. J Hypertens. 2001;19:1699–705.
Iwasaki K, Zhang R, Perhonen MA, Zuckerman JH, Levine BD. Reduced baroreflex control of heart period after bed rest is normalized by acute plasma volume restoration. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1256–62.
Saitoh T, Ogawa Y, Aoki K, Shibata S, Otsubo A, Kato J, Iwasaki K. Bell-shaped relationship between central blood volume and spontaneous baroreflex function. Auton Neurosci. 2008;143:46–52.
Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function analysis of the circulation: unique insights into cardiovascular regulation. Am J Physiol. 1991;261:H1231–45.
Triedman JK, Cohen RJ, Saul JP. Mild hypovolemic stress alters autonomic modulation of heart rate. Hypertension. 1993;21:236–47.
Ogawa Y, Iwasaki K, Aoki K, Kojima W, Kato J, Ogawa S. Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thigh cuff method. Anesthesiology. 2008;109:642–50.
Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705.
Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95:461–6.
Prielipp RC, Wall MH, Tobin JR, Groban L, Cannon MA, Fahey FH, Gage HD, Stump DA, James RL, Bennett J, Butterworth J. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002;95:1052–9.
Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–51.
Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension. 1995;25:1276–86.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996; 93:1043–65.
Dietrich A, Riese H, van Roon AM, van Engelen K, Ormel J, Neeleman J, Rosmalen JGM. Spontaneous baroreflex sensitivity in (pre)adolescents. J Hypertens. 2006;24:345–52.
Pinna GD, Maestri R. New criteria for estimating baroreflex sensitivity using the transfer function method. Med Biol Eng Comput. 2002;40:79–84.
Ogawa Y, Iwasaki K, Shibata S, Kato J, Ogawa S, Oi Y. Different effects on circulatory control during volatile induction and maintenance of anesthesia and total intravenous anesthesia: autonomic nervous activity and arterial cardiac baroreflex function evaluated by blood pressure and heart rate variability analysis. J Clin Anesth. 2006;18:87–95.
Introna R, Blair J, Martin DC. Measurement of the low-frequency component of blood pressure variability can assist the interpretation of heart rate variability data. Anesthesiology. 2003;99:237.
Muzi M, Goff DR, Kampine JP, Roerig DL, Ebert TJ. Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology. 1992;77:864–71.
Parati G, Di Rienzo M, Castiglioni P, Mancia G, Taylor JA, Studinger P. Point: counterpoint: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol. 2006;101:676–82.
Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–33.
Acknowledgments
Financial support for this work was partly provided by Hospira Japan K.K. (Osaka, Japan) and institutional funding.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ehara, T., Ogawa, Y., Kato, J. et al. The effect of dexmedetomidine on arterial-cardiac baroreflex function assessed by spectral and transfer function analysis. J Anesth 26, 483–489 (2012). https://doi.org/10.1007/s00540-012-1363-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-012-1363-0